Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Construction Begins on Temecula Valley Hospital
Ground was broken on the new Temecula Valley Hospital in June of 2011. The five-story, 178,000-sf acute care facility is being developed by Universal Health Services Design and Construction. The project team includes HMC Architects, DPR Construction, and Turner Construction Company. The 140-bed facility will feature entirely private rooms, a flexible emergency department, a 20-bed ICU, six surgical suites, and advanced imaging technologies.
Roche Attains LEED Gold for Renovation Project
Roche has attained LEED Gold sustainable design certification for the renovation of Building 76 in Nutley, N.J. The project included refurbishment of 159,000 sf on nine floors. The completed Building 76 features daylight harvesting, chilled beams, occupancy sensors, and an advanced HVAC system. Construction began in September of 2009. The project team included design architect HDR, Sordoni Construction, and Dauo Engineers.
Christopher Newport University Breaks Ground on Teaching and Research Facility
Christopher Newport University will break ground in July of 2011 on the $54.6 million Joseph W. Luter III Building in Newport News, Va. The 135,622-sf facility will provide advanced teaching and research labs, faculty offices, and classrooms for seven departments. The project will also house the Luter School of Business.
CMC Biologics Expands in Bothell
CMC Biologics is expanding its bioprocessing facility in Bothell, Wash., to house a 3,000-liter bioreactor train. Two 5,000-liter commercial-ready manufacturing lines will also be constructed. The project will support cGMP manufacturing of biopharmaceuticals.
Novartis Builds St. Petersburg Manufacturing Plant
Novartis broke ground in June of 2011 on a pharmaceutical manufacturing plant in St. Petersburg, Russia. Part of a five-year, $500 million investment, the facility will utilize advanced technologies to produce innovative therapeutics and generics. Completion is expected in 2014.